Aurobindo Pharma Declares Dividend Of Rs 4 — Check Record Date, Details
The company reported a 10% decline in its net profit on an annual basis for the first quarter of fiscal 2026.
Aurobindo Pharma Ltd. announced on Monday an interim dividend of Rs 4 per equity share with a face value of Re 1 for the first quarter of fiscal 2026.
The board has fixed Aug. 8 as the record date for the purpose of dividend payment. The company will pay the interim dividend on or before Aug. 21, it said in an exchange filing. The total amount to be disbursed as dividend to the stakeholders is approximately Rs 232 crore.
The company reported a 10% decline in its consolidated net profit on an annual basis for the first quarter of fiscal 2026. The company reported a bottom line of Rs 824.7 crore in the quarter ended June.
Aurobindo Pharma Q1 FY26 Highlights (Consolidated, YoY)
Revenue up 4% to Rs 7,868 crore versus Rs 7,567 crore (Estimate: Rs 8,196.60 crore).
Net Profit down 10% to Rs 824.7 crore versus Rs 919 crore (Estimate: Rs 940 crore).
Ebitda down 1% to Rs 1,602.9 crore versus Rs 1,619.4 crore (Estimate: Rs 1,726.6 crore).
Margin at 20.4% versus 21.4% (Estimate: 21.06%).
The stock settled 1.13% higher at Rs 1,090.4 apiece on the National Stock Exchange before the announcement, compared to a 0.64% decline in the benchmark Nifty. Aurobindo Pharma's shares have fallen 24.45% over the past 12 months and 18.29% on a year-to-date basis.
Out of the 29 analysts tracking the company, 23 maintain a 'buy' rating, one recommend a 'hold' and five suggest 'sell', according to Bloomberg data. The average of 12-month analysts' price target implies an upside of 26.4%.
